Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Parambil
Impact of Switching From Epoprostenol to IV Treprostinil on Treatment Satisfaction and Quality of Life in Patients With Pulmonary Hypertension
Respiratory Medicine
Pulmonary
Respiratory Medicine
Related publications
Treatment Satisfaction Is Associated With Improved Quality of Life in Patients Treated With Inhaled Treprostinil for Pulmonary Arterial Hypertension
Health and Quality of Life Outcomes
Medicine
Environmental
Public Health
Occupational Health
Prs9 - Switching From Subcutaneous Treprostinil to Inhaled Treprostinil in Pulmonary Arterial Hypertension Treatment and Economic Impact Evaluation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Transition of Stable Pediatric Patients With Pulmonary Arterial Hypertension From Intravenous Epoprostenol to Intravenous Treprostinil
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Epoprostenol Treatment in Children With Severe Pulmonary Hypertension
Heart
Cardiovascular Medicine
Cardiology
Rapid Transition From Inhaled Iloprost to Inhaled Treprostinil in Patients With Pulmonary Arterial Hypertension
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
Treatment Satisfaction and Quality of Life in Patients Treated With Fingolimod
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Epoprostenol Treatment for Idiopathic Pulmonary Arterial Hypertension in Pregnancy
Journal of Perinatology
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Quality of Life in Pulmonary Arterial Hypertension: Qualitative Insights From Patients and Caregivers
Advances in Pulmonary Hypertension
Tolerability and Clinical Efficacy of Inhaled Treprostinil in Patients With Group 1 Pulmonary Arterial Hypertension
Therapeutic Advances in Chronic Disease
Medicine